The MAPK1E322K hotspot mutation, which causes constitutive activation of ERK2 [7, 8], occurs in approximate 1.3% of HNSCC [9, 10] and in 8% of cervical squamous cell carcinomas [11]. This evidence concerns the gene MAPK1 and head and neck squamous cell carcinoma.